Frontiers in Oncology | Cancer Molecular Targets and Therapeutics

Original Research

Published on 10 Oct 2023

Survival analysis of patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment of Yunnan in southwestern China: a real-world study

in Cancer Molecular Targets and Therapeutics

Yanping Lin
Long Chen
Rong Li
Xin Liu
Quan Li
Jingjing Cai
Yaxi Du
Guangqiang Zhao
Xiaoxiong Wang
Zhenghai Shen

Frontiers in Oncology

doi 10.3389/fonc.2023.1156647

2,539 views
2 citations

Case Report

Published on 05 Oct 2023

Case Report: Ensartinib for gastric epithelioid inflammatory myofibrosarcoma with STRN-ALK fusion

in Cancer Molecular Targets and Therapeutics

XiaoQing Li
JingFan Zheng
XinYi Li
YuYu Chen
Kang Liu
FangChao Li
Zhong Lu

Frontiers in Oncology

doi 10.3389/fonc.2023.1252221

2,233 views
8 citations

Review

Published on 04 Oct 2023

Use and accuracy of decision support systems using artificial intelligence for tumor diseases: a systematic review and meta-analysis

in Cancer Molecular Targets and Therapeutics

Robert Oehring
Nikitha Ramasetti
Sharlyn Ng
Roland Roller
Philippe Thomas
Axel Winter
Max Maurer
Simon Moosburner
Nathanael Raschzok
Can Kamali

Frontiers in Oncology

doi 10.3389/fonc.2023.1224347

5,050 views
9 citations

Original Research

Published on 29 Sep 2023

Phenotypic heterogeneity drives differential disease outcome in a mouse model of triple negative breast cancer

in Cancer Molecular Targets and Therapeutics

Archana P. Thankamony
Sonny Ramkomuth
Shikha T. Ramesh
Reshma Murali
Priyanka Chakraborty
Nitheesh Karthikeyan
Binitha Anu Varghese
Vishnu Sunil Jaikumar
Mohit Kumar Jolly
Alexander Swarbrick

Frontiers in Oncology

doi 10.3389/fonc.2023.1230647

3,094 views
5 citations

Systematic Review

Published on 29 Sep 2023

Arthralgia adverse events due to immune-checkpoint inhibitors for lung cancer patients: a systematic review and meta-analysis

in Cancer Molecular Targets and Therapeutics

Defang Zou
Xiaoping Wang
Yamin Sun
Xi Wang
Chang Lu
Aiyun Wang
Xia Wang
Yan Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1258287

2,806 views
3 citations

Retraction

Published on 28 Sep 2023

Retraction: AnnexinA5 might suppress the phenotype of human gastric cancer cells via ERK pathway

in Cancer Molecular Targets and Therapeutics

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2023.1294881

1,567 views

Case Report

Published on 27 Sep 2023

Case report: The activity of multi-kinase VEGF inhibitor, Pazopanib, in metastatic undifferentiated round cell sarcomas harboring EWSR1::CREM fusion: clinicopathological series of two cases and literature review

in Cancer Molecular Targets and Therapeutics

Leticia Campoverde
Felipe Camacho
Francesco Alessandrino
Mark G. Evans
Andrew Elliot
Andrew Rosenberg
Jonathan Trent

Frontiers in Oncology

doi 10.3389/fonc.2023.1215003

3,224 views
4 citations

Original Research

Published on 25 Sep 2023

Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model

in Cancer Molecular Targets and Therapeutics

Dalton T. McLean
Jennifer J. Meudt
Loren D. Lopez Rivera
Dominic T. Schomberg
Derek M. Pavelec
Tyler T. Duellman
Darya G. Buehler
Patrick B. Schwartz
Melissa Graham
Laura M. Lee

Frontiers in Oncology

doi 10.3389/fonc.2023.1253659

5,670 views
3 citations

Systematic Review

Published on 25 Sep 2023

The efficacy and safety of different systemic combination therapies on advanced hepatocellular carcinoma: a systematic review and meta-analysis

in Cancer Molecular Targets and Therapeutics

Ping Li
Ming Hu
Mei Liu
Xiangyu Ren
Donghong Liu
Jiluo Liu
Jianhua Yin
Xiaojie Tan
Guangwen Cao

Frontiers in Oncology

doi 10.3389/fonc.2023.1197782

2,434 views
4 citations

Original Research

Published on 25 Sep 2023

Revolutionizing anti-cancer drug discovery against breast cancer and lung cancer by modification of natural genistein: an advanced computational and drug design approach

in Cancer Molecular Targets and Therapeutics

Shopnil Akash
Shabana Bibi
Partha Biswas
Nobendu Mukerjee
Dhrubo Ahmed Khan
Md. Nazmul Hasan
Nazneen Ahmeda Sultana
Md. Eram Hosen
Yousef A. Bin Jardan
Hiba-Allah Nafidi

Frontiers in Oncology

doi 10.3389/fonc.2023.1228865

7,006 views
21 citations

Original Research

Published on 22 Sep 2023

Development, quality, and influencing factors of colonoscopy in China: results from the national census in 2013 and 2020

in Cancer Molecular Targets and Therapeutics

Yun-Fei Jiao
Zhi-Yuan Cheng
Ye Gao
Chu-Ting Yu
Hui-Shan Jiang
Ting-Lu Wang
Ying Deng
Han Lin
Tian-Jiao Wang
Wei Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1276520

2,804 views
4 citations

Case Report

Published on 19 Sep 2023

The novel EGFR mutations (p.E746_S752delinsI, p.T751_I759delinsG, p.L747_S752delinsAA) in patients with non-small cell lung cancer and the clinical treatment strategy: three case reports

in Cancer Molecular Targets and Therapeutics

Yamin Meng
Xiaodong Li
Lei Zhang
Minhua Ye

Frontiers in Oncology

doi 10.3389/fonc.2023.1129629

3,709 views
1 citation

Mini Review

Published on 15 Sep 2023

Beyond liver cancer, more application scenarios for alpha-fetoprotein in clinical practice

in Cancer Molecular Targets and Therapeutics

Chenyu Ma
Yuexinzi Jin
Yuhan Wang
Huaguo Xu
Jiexin Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1231420

2,406 views
3 citations

Original Research

Published on 14 Sep 2023

LTe2 induces cell apoptosis in multiple myeloma by suppressing AKT phosphorylation at Thr308 and Ser473

in Cancer Molecular Targets and Therapeutics

Yuanjiao Zhang
Jiacheng Qian
Mingmei Jiang
Shu Yang
Lianxin Zhou
Qin Zhang
Liping Lin
Ye Yang

Frontiers in Oncology

doi 10.3389/fonc.2023.1269670

1,887 views
1 citation

Hypothesis and Theory

Published on 14 Sep 2023

Opioids and immune checkpoint inhibitors differentially regulate a common immune network in triple-negative breast cancer

in Cancer Molecular Targets and Therapeutics

Joseph R. Scarpa
Giacomo Montagna
George Plitas
Amitabh Gulati
Gregory W. Fischer
Joshua S. Mincer

Frontiers in Oncology

doi 10.3389/fonc.2023.1267532

2,562 views
6 citations

Original Research

Published on 13 Sep 2023

System analysis based on the lysosome-related genes identifies HPS4 as a novel therapy target for liver hepatocellular carcinoma

in Cancer Molecular Targets and Therapeutics

Ke‐Jie He
Zhiqiang Nie

Frontiers in Oncology

doi 10.3389/fonc.2023.1221498

1,924 views
1 citation